Sfoglia per Autore
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens.
2014-01-01 De Nicolò A;Simiele M;Calcagno A;Mohamed Abdi A;Bonora S;Di Perri G;D'Avolio A
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells.
2014-01-01 De Nicolò A;Agnesod D;Simiele M;Riganò D;Adriani A;Canaparo R;Astegiano M;Rizzetto M;Di Perri G;D'Avolio A
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms.
2014-01-01 Boglione L;Cusato J;De Nicolò A;Cariti G;Allegra S;Ghisetti V; Di Perri G;D'Avolio A
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir
2014-01-01 Boglione, Lucio; DE NICOLO', Amedeo; Cusato, Jessica; Cariti, G.; DI PERRI, Giovanni; D'Avolio, Antonio
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E.
2014-01-01 Boglione L;Cardellino CS;De Nicolò A;Cariti G;Di Perri G;D'Avolio A
VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.
2015-01-01 Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
ITPA gene variants as markers of ribavirin-induced anemia and white blood cells reduction in Egyptian HCV patients
2015-01-01 Abdelhafez, A; Cusato, J; Hussein, A; Kamel, S; De Nicolo', A; Di Perri, G; D'Avolio, A; El Desoky, E
High four weeks’ entecavir plasma concentration is a negative predictor of HBV DNA drop after three months of therapy
2015-01-01 A. De Nicolò; L. Boglione; L. Baietto; C.S. Cardellino; M. Simiele; G. Cariti; G. Di Perri; A. D'Avolio
Vitamin D pathway polymorphisms impact on HBV interferon treatment outcomes in a cohort of HBeAg negative patients
2015-01-01 Cusato, Jessica; Boglione, Lucio; De Nicolo’, Amedeo; Cardellino, Chiara Simona; Imbornone, Rosaria; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir.
2015-01-01 Cusato, Jessica; De Nicolo’, Amedeo; Boglione, Lucio; Cardellino, Chiara Simona; Allegra, Sarah; Bonifacio, Gabriele; Cariti, Giuseppe; Giovanni Di Perri, ; D’Avolio, Antonio
A LC-MS method to quantify tenofovir urinary concentrations in treated patients
2015-01-01 Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.
2015-01-01 Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Baietto, Lorena; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients
2015-01-01 Allegra, Sarah; Cusato, Jessica; DE NICOLO', Amedeo; Boglione, Lucio; Alberto, Gatto; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics
2015-01-01 Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Adnan Mohamed Abdi, ; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio
Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon.
2015-01-01 Boglione L;Cusato J;De Nicolò A;Cariti G;Di Perri G;D'Avolio A
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir
2015-01-01 Milazzo L; Peri AM; Mazzali C; Magni C; Calvi E; De Nicolò A; Clementi E; Cheli S; D'Avolio A; Antinori S; Falvella FS
Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy
2015-01-01 Boglione, Lucio; DE NICOLO', Amedeo; Chiara Simona Cardellino, ; Tina, Ruggiero; Valeria, Ghisetti; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.
2015-01-01 Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
An UPLC MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in Peripheral Blood Mononuclear Cells
2015-01-01 Pensi, Debora; DE NICOLO', Amedeo; Pinon, Michele; Pier Luigi Calvo, ; Antonello, Nonnato; Brunati, Andrea; DI PERRI, Giovanni; D'Avolio, Antonio
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir
2015-01-01 Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Mohamed Abdi, Adnan; Cariti, Giuseppe; DI PERRI, Giovanni; D'Avolio, Antonio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens. | 2014 | De Nicolò A;Simiele M;Calcagno A;Mohamed Abdi A;Bonora S;Di Perri G;D'Avolio A | |
| UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. | 2014 | De Nicolò A;Agnesod D;Simiele M;Riganò D;Adriani A;Canaparo R;Astegiano M;Rizzetto M;Di Perri G;D'Avolio A | |
| Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. | 2014 | Boglione L;Cusato J;De Nicolò A;Cariti G;Allegra S;Ghisetti V; Di Perri G;D'Avolio A | |
| Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir | 2014 | Boglione, Lucio; DE NICOLO', Amedeo; Cusato, Jessica; Cariti, G.; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E. | 2014 | Boglione L;Cardellino CS;De Nicolò A;Cariti G;Di Perri G;D'Avolio A | |
| VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. | 2015 | Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio | |
| ITPA gene variants as markers of ribavirin-induced anemia and white blood cells reduction in Egyptian HCV patients | 2015 | Abdelhafez, A; Cusato, J; Hussein, A; Kamel, S; De Nicolo', A; Di Perri, G; D'Avolio, A; El Desoky, E | |
| High four weeks’ entecavir plasma concentration is a negative predictor of HBV DNA drop after three months of therapy | 2015 | A. De Nicolò; L. Boglione; L. Baietto; C.S. Cardellino; M. Simiele; G. Cariti; G. Di Perri; A. D'Avolio | |
| Vitamin D pathway polymorphisms impact on HBV interferon treatment outcomes in a cohort of HBeAg negative patients | 2015 | Cusato, Jessica; Boglione, Lucio; De Nicolo’, Amedeo; Cardellino, Chiara Simona; Imbornone, Rosaria; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio | |
| Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir. | 2015 | Cusato, Jessica; De Nicolo’, Amedeo; Boglione, Lucio; Cardellino, Chiara Simona; Allegra, Sarah; Bonifacio, Gabriele; Cariti, Giuseppe; Giovanni Di Perri, ; D’Avolio, Antonio | |
| A LC-MS method to quantify tenofovir urinary concentrations in treated patients | 2015 | Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. | 2015 | Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Baietto, Lorena; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients | 2015 | Allegra, Sarah; Cusato, Jessica; DE NICOLO', Amedeo; Boglione, Lucio; Alberto, Gatto; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics | 2015 | Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Adnan Mohamed Abdi, ; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. | 2015 | Boglione L;Cusato J;De Nicolò A;Cariti G;Di Perri G;D'Avolio A | |
| SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir | 2015 | Milazzo L; Peri AM; Mazzali C; Magni C; Calvi E; De Nicolò A; Clementi E; Cheli S; D'Avolio A; Antinori S; Falvella FS | |
| Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy | 2015 | Boglione, Lucio; DE NICOLO', Amedeo; Chiara Simona Cardellino, ; Tina, Ruggiero; Valeria, Ghisetti; Giuseppe, Cariti; DI PERRI, Giovanni; D'Avolio, Antonio | |
| VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. | 2015 | Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio | |
| An UPLC MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in Peripheral Blood Mononuclear Cells | 2015 | Pensi, Debora; DE NICOLO', Amedeo; Pinon, Michele; Pier Luigi Calvo, ; Antonello, Nonnato; Brunati, Andrea; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir | 2015 | Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Mohamed Abdi, Adnan; Cariti, Giuseppe; DI PERRI, Giovanni; D'Avolio, Antonio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile